Richard Unwin, Associate Editor
University of Manchester, UK
Richard Unwin graduated from the University of Nottingham with a BSc in Biology and MSc in Oncology before obtaining his PhD from the University of Leeds in 2001 in what was then the new field of proteomics. He subsequently joined The University of Manchester, developing new methods for analysing cancer proteomes, including isobaric tagging, global and targeted analysis of protein phosphorylation, and methods for comparing proteomic and transcriptomic data.
In 2010 he moved to manage a new mass spectrometry research laboratory within the UK National Health Service, where he worked on the study of proteins and metabolites in chronic disease, and developed new targeted assays which have now been moved into hospital laboratories.
Richard moved back to the University of Manchester in 2017 to continue a research programme developing tools for mass spectrometry data acquisition and analysis for the study of age-related chronic diseases. He collaborates widely with academic and commercial partners and has also established a spin-out company, Complement Therapeutics, to develop novel therapeutics and an accompanying precision medicine platform for conditions characterised by dysregulation of the complement system.